OPTIRAY 350 (350 mg I/ml), solution for injection in a vial bottle, 50 ml, CIP 3400933277017
Active ingredients: Iodine, Ioversol
Commercialized according to BDPMDispensing in France: Prescription only
Solution for injectionbottle, 50 ml, CIP 3400933277017intraartérielle;intraveineuse
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- OPTIRAY 350 (350 mg I/mL), solution injectable en flacon
- Pharmaceutical form
- solution injectable
- Route of administration
- intraartérielle;intraveineuse
- Presentation description
- 1 flacon(s) en verre de 50 ml - avec seringue(s) - polypropylène - avec matériel de perfusion
- Marketing authorisation holder
- GUERBET
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 30 Oct 2024
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
65772900CIP73327701CIP133400933277017Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| IODEsolution | 35,0 g · 100 ml | FT |
| IOVERSOLsolution | 74,2 g · 100 ml | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
- bottle, 500 mlCommercialized according to BDPM
- bottle, 50 ml, CIP 3400933276645Commercialized according to BDPM
- bottle, 100 mlCommercialized according to BDPM
- bottle, 200 mlCommercialized according to BDPM
- 25 bottles of 50 mlCommercialized according to BDPM
- 10 bottles of 100 mlCommercialized according to BDPM
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.